In contrast, we showed that OTUD1 depletion decreased the apoptosis of renal cancer cells treated with sunitinib (Fig. 5G-J) and increased the IC50 values of sunitinib in 786-O and ACHN cells (Fig. 5K). Here, OTUD1 is linked to renal carcinoma.